INS and cancer: If exogenous insulin did contribute to the observed association, the strength of the relationship between type 1 diabetes and cancer incidence would be expected to be stronger than that observed among persons with type 2 diabetes because all people with type 1 diabetes are treated with insulin and a minority of people with type 2 diabetes receive insulin treatment.